Informations générales
  • Catégorie de maladie Maladies néonatales , Grossesse et accouchement (BASEC)
  • Study Phase N/A (ICTRP)
  • État du recrutement recrutement en cours (BASEC/ICTRP)
  • Lieu de l’étude
    Bâle, St-Gall, Winterthur, Zurich, Autre
    (BASEC)
  • Responsable de l'étude Tilo Burkhardt tilo.burkhardt@usz.ch (BASEC)
  • Source(s) de données BASEC: Importé de 03.09.2024 ICTRP: Importé de 09.11.2023
  • Date de mise à jour 24.02.2025 11:18
HumRes43390 | SNCTP000003853 | BASEC2018-01842 | NCT03693885

Contraction stress test before planned cesarean section to reduce the risk of neonatal respiratory distress syndrome.

  • Catégorie de maladie Maladies néonatales , Grossesse et accouchement (BASEC)
  • Study Phase N/A (ICTRP)
  • État du recrutement recrutement en cours (BASEC/ICTRP)
  • Lieu de l’étude
    Bâle, St-Gall, Winterthur, Zurich, Autre
    (BASEC)
  • Responsable de l'étude Tilo Burkhardt tilo.burkhardt@usz.ch (BASEC)
  • Source(s) de données BASEC: Importé de 03.09.2024 ICTRP: Importé de 09.11.2023
  • Date de mise à jour 24.02.2025 11:18

Résumé de l'étude

Children born by cesarean section without prior contractions have an increased risk of adaptation disorders with respiratory problems. The reason for this is that without contractions, no stress hormones are released in the child and its mother at the time of birth, which improves adaptation to postnatal conditions. Accordingly, children with a normal vaginal birth have much less frequently adaptation problems and their mothers have fewer issues with the initiation and success of breastfeeding. A contraction stress test before a planned cesarean section leads to an increase in stress hormones similar to that of children after a normal vaginal birth. For measuring stress hormone levels, the stable cleavage product of the stress hormone vasopressin, copeptin, is particularly suitable. This study will include pregnant women with more than 34 weeks of gestation and a planned primary cesarean section, meaning that neither the amniotic sac has ruptured nor have spontaneous contractions started. Exclusion criteria are set as follows: pregnancies before 35+0 weeks of gestation, multiple pregnancies, fetal growth retardation, fetal malformations, suspicious CTG, contraindications for the induction of contractions such as placenta previa, internal diseases of the pregnant woman which are contraindications for the administration of oxytocin. The study intervention is the performance of a contraction stress test a few hours before the planned cesarean section. This means that oxytocin will be administered until regular contractions are recorded every 3 minutes with the contraction monitor or are palpable through the abdominal wall. After birth, 5 ml of umbilical cord blood will be collected from the placenta to measure stress hormones and precursor cells, as well as stool samples from the children and maternal milk samples from the mother, to examine possible effects of contraction stress on the infant and maternal microbiome.

(BASEC)

Intervention étudiée

Contraction stress test before performing a planned cesarean section

(BASEC)

Maladie en cours d'investigation

Neonatal respiratory distress syndrome after a cesarean section without prior contractions. Influence of contractions on breastfeeding rates.

(BASEC)

Critères de participation
Singleton pregnancies ≥ 35 completed weeks of gestation Planned cesarean section (BASEC)

Critères d'exclusion
More than one cesarean section in the medical history, Multiple pregnancies (twins, triplets, etc.), Any contraindications for contractions, e.g. transverse position, placenta previa, history of myomectomy with uterine cavity opening, history of longitudinal cesarean, Severe fetal malformations: syndromic diseases, heart defects, arrhythmias, gastrointestinal malformations, Oligohydramnios or hydramnios, Intrauterine growth restriction (<5th percentile), Suspicious or pathological CTG, Signs of peripartum infection, clinically or laboratory-wise (CRP or leukocyte increase in the pregnant woman), Internal diseases of the pregnant woman that are contraindications for the administration of oxytocin (heart defects, arrhythmias) (BASEC)

Lieu de l’étude

Bâle, St-Gall, Winterthur, Zurich, Autre

(BASEC)

Baden

(BASEC)

Switzerland (ICTRP)

Sponsor

non disponible

Contact pour plus d'informations sur l'étude

Personne de contact en Suisse

Tilo Burkhardt

+41 44 255 51 92

tilo.burkhardt@usz.ch

(BASEC)

Informations générales

Dept. of Obstetrics, University Hospital Zurich,

+41 44 255 5192

tilo.burkhardt@usz.ch

(ICTRP)

Informations scientifiques

Dept. of Obstetrics, University Hospital Zurich,

+41 44 255 5192

tilo.burkhardt@usz.ch

(ICTRP)

Nom du comité d'éthique approbateur (pour les études multicentriques, uniquement le comité principal)

Commission cantonale de Zurich

(BASEC)

Date d'approbation du comité d'éthique

15.02.2019

(BASEC)


Identifiant de l'essai ICTRP
NCT03693885 (ICTRP)

Titre officiel (approuvé par le comité d'éthique)
non disponible

Titre académique
Mild Induced Labour Prior to Planned Caesarean Delivery to Improve Neonatal and Maternal Outcome - a Randomized Trial (ICTRP)

Titre public
Oxytocin Administration Prior Planned Caesarean Section (ICTRP)

Maladie en cours d'investigation
Respiratory Insufficiency Syndrome of Newborn;Breastfeeding Status (ICTRP)

Intervention étudiée
Other: Oxytocin challenge test (OCT) (ICTRP)

Type d'essai
Interventional (ICTRP)

Plan de l'étude
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label). (ICTRP)

Critères d'inclusion/exclusion
Gender: Female
Maximum age: N/A
Minimum age: 18 Years

Inclusion Criteria:

- Singleton pregnancy >34 weeks

- primary caesarean section, that is without preceding contractions or rupture of the
membranes,

- absence of a contraindication to oxytocin

Exclusion Criteria:

- Chromosomal aberration

- malformation,

- IUGR,

- Nonreassuring fetal heart rate pattern,

- Placenta praevia,

- maternal substance abuse,

- infections,

- hypertension,

- preeclampsia,

- diabetes type I or II,

- autoimmune disease (antiphospholipid syndrome, lupus erythematosus, etc.),

- renal disease,

- history of more than one previous caesarean section.
(ICTRP)

non disponible

Critères d'évaluation principaux et secondaires
Incidence of neonatal respiratory morbidity (ICTRP)

Umbilical cord blood copeptin levels;Postnatal neonatal weight change;Breastfeeding status (ICTRP)

Date d'enregistrement
non disponible

Inclusion du premier participant
non disponible

Sponsors secondaires
University of Basel (ICTRP)

Contacts supplémentaires
Tilo Burkhardt, MD;Tilo Burkhardt, MD, tilo.burkhardt@usz.ch, +41 44 255 5192, Dept. of Obstetrics, University Hospital Zurich, (ICTRP)

ID secondaires
Lacarus (ICTRP)

Résultats-Données individuelles des participants
No (ICTRP)

Informations complémentaires sur l'essai
https://clinicaltrials.gov/ct2/show/NCT03693885 (ICTRP)


Résultats de l'essai

Résumé des résultats

non disponible

Lien vers les résultats dans le registre primaire

non disponible